Related Experiment Video
Updated: Jan 6, 2026

11:02
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
19.8K
Whole-Exome Sequencing (WES) for Illumina Short Read Sequencers Using Solution-Based Capture.
Milind C Mahajan1, Andrew S McLellan2
1Sema4, a Mount Sinai venture, Stamford, CT, USA.
Methods in Molecular Biology (Clifton, N.J.)
|October 6, 2019
Summary
Next-generation sequencing (NGS) and whole-exome sequencing (WES) advance genetic mutation identification for diagnostics and personalized medicine. This protocol details WES library preparation and exome enrichment for clinical applications.
Area of Science:
- Genomics
- Molecular Biology
- Clinical Diagnostics
Background:
- Next-generation sequencing (NGS) revolutionizes clinical research and diagnostics by identifying genetic mutations.
- Whole-exome sequencing (WES) targets coding regions, capturing most disease-causing mutations for comprehensive analysis.
- WES supports personalized medicine by informing diagnosis, therapeutic strategies, and disease risk prediction.
Purpose of the Study:
- To present a detailed protocol for performing whole-exome sequencing (WES).
- To outline steps for genomic DNA extraction, library preparation, and exome enrichment.
- To describe quality control methods including purification and qPCR for assessing capture efficiency.
Main Methods:
- Genomic DNA (gDNA) extraction from blood or saliva.
- Library preparation for Illumina sequencing instruments.
- Exome enrichment using Roche NimbleGen SeqCap EZ Exome v3 kit.
- Purification using AMPure XP System and quality assessment via qPCR.
Main Results:
- A standardized protocol for WES is established.
- Efficient purification and quality control methods are detailed.
- The protocol facilitates the identification of genetic variations for clinical applications.
Conclusions:
- The described WES protocol enables robust genetic analysis for clinical research and diagnostics.
- This method supports personalized medicine by identifying actionable genetic information.
- The protocol provides a foundation for utilizing WES data in understanding complex diseases.
More Related Videos
Related Concept Videos
RNA-seq
11.7K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
11.7K
Next-generation Sequencing
97.5K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.5K
Sanger Sequencing
772.7K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
772.7K

